IL116827A - Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis - Google Patents

Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis

Info

Publication number
IL116827A
IL116827A IL11682796A IL11682796A IL116827A IL 116827 A IL116827 A IL 116827A IL 11682796 A IL11682796 A IL 11682796A IL 11682796 A IL11682796 A IL 11682796A IL 116827 A IL116827 A IL 116827A
Authority
IL
Israel
Prior art keywords
prophylaxis
preparation
pharmaceutical compositions
vasodilatory
treatment
Prior art date
Application number
IL11682796A
Other languages
English (en)
Other versions
IL116827A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116827A0 publication Critical patent/IL116827A0/xx
Publication of IL116827A publication Critical patent/IL116827A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11682796A 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis IL116827A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK6795 1995-01-20
DK77595 1995-06-30

Publications (2)

Publication Number Publication Date
IL116827A0 IL116827A0 (en) 1996-05-14
IL116827A true IL116827A (en) 1999-11-30

Family

ID=26063230

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11682796A IL116827A (en) 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis

Country Status (13)

Country Link
US (1) US5886021A (xx)
EP (1) EP0804188A1 (xx)
JP (1) JPH10513154A (xx)
KR (1) KR19980701548A (xx)
CN (1) CN1168100A (xx)
AU (1) AU4329196A (xx)
BR (1) BR9606767A (xx)
CA (1) CA2208852A1 (xx)
CZ (1) CZ211897A3 (xx)
HU (1) HUP9800297A3 (xx)
IL (1) IL116827A (xx)
NO (1) NO973341D0 (xx)
WO (1) WO1996022093A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
NZ711603A (en) 2014-02-07 2017-05-26 Novogen ltd Functionalised benzopyran compounds and use thereof
PL3253208T3 (pl) 2015-02-02 2021-11-08 Mei Pharma, Inc. Terapie kombinowane do zastosowania w leczeniu nowotworu piersi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
BR9606767A (pt) 1997-12-30
AU4329196A (en) 1996-08-07
HUP9800297A2 (hu) 1998-12-28
CA2208852A1 (en) 1996-07-25
KR19980701548A (ko) 1998-05-15
JPH10513154A (ja) 1998-12-15
MX9705379A (es) 1997-10-31
IL116827A0 (en) 1996-05-14
CZ211897A3 (en) 1997-12-17
NO973341L (no) 1997-07-18
WO1996022093A1 (en) 1996-07-25
NO973341D0 (no) 1997-07-18
US5886021A (en) 1999-03-23
HUP9800297A3 (en) 1999-12-28
EP0804188A1 (en) 1997-11-05
CN1168100A (zh) 1997-12-17

Similar Documents

Publication Publication Date Title
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL139658A0 (en) Pharmaceutical compositions for treatment and prophylaxis and method for their preparation
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
AU1367397A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
IL124882A0 (en) Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL117655A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
IL116826A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
IL116827A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis
EP0852503A4 (en) AGENTS FOR THE TREATMENT OF DIARRHÖ, THEIR USE AND PRODUCTION
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
HUP9702293A3 (en) 4-thiazolidinone, rhodanine and 1,3-oxathiolan-5-one derivatives for the preparation of pharmaceutical compositions suitable for the treatment of multiple sclerosis
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
IL116747A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis
HU9700437D0 (en) Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted